跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,868 条关于
“Navamedic ASA”
全部
4,868
临床试验
3,276
药物
572
机构
544
资讯
476
去年
Navamedic Expands Into Addiction Treatment with NOK 225 Million Acquisition of DNE Pharma
去年
Ultimovacs Announces Q3 2024 Results and Strategic Update
去年
Ultimovacs ASA Provides Update on Clinical Trials and Financial Strategy
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
去年
Vertex's Non-Opioid Suzetrigine Shows Promise in Phase 3 Acute Pain Trials
去年
Ultimovacs' UV1 Fails to Improve Outcomes in Head and Neck Cancer Trial
3个月前
Risk Analysis Index Outperforms Traditional Metrics in Predicting Mortality After Distal Femur Fracture Surgery
5个月前
FDA Plans Reclassification of Diagnostic Endoscopic Light Source Systems Used in Bladder Cancer Detection
去年
Ketamine Use Surges 40% in U.S. as Medical Authorities Call for Stricter Controls
第 1 页,共 48 页
上一页
下一页